A new study from Israel indicates that the South African variant of the coronavirus can “break through” the Pfizer / BioNTech vaccine to a certain extent.
A team from the University of Tel Aviv and Clalit Health Services found that the incidence of the South African variant among patients who received both doses of the vaccine was about eight times higher than those who had not been vaccinated – 5, 4% versus 0.7%.
The study compared more than 400 people who received at least one shot of the vaccine and contracted the coronavirus with the same number who had been infected and vaccinated.
CHINESE COVID-19 EFFECTIVE EFFICIENCY ‘NOT HIGH’, GOVERNMENT DISCOVER OPTIONS: OFFICIALS
“We found an excessively higher percentage of the South African variant among people who were vaccinated with a second dose, compared to the group who were not vaccinated,” said Adi Stern of Tel Aviv University. “This means that the South African variant can to some extent break through the protection of the vaccine.”
The study, published Saturday, still requires peer review to verify the results, according to Reuters.
RECEIVING IN ITALY THAT MAFIA VACCINES TO FRIENDS WORK FIRST STRONG
“This is the first in the world based on actual data, which shows that the vaccine is less effective against the South African variant, compared to the original virus and the British variant,” said Professor Ran Balicer, director of research. said at Clalit.
Balicer noted that the results point to the need for continued health policies, including social distance and wearing masks in indoor spaces.
COMMANDED ADMINISTRATION DENIAL WITTER’S REQUEST FOR EXTRA ENKTO IN MUNICIPAL CASES IN MICHIGAN
The study appears to confirm a recent study by Ben-Gurion University of the Negev, according to the Times of Israel: The Ben-Gurion study analyzed blood samples, while the new research is based on sequence of test results.
In particular, the new study does not indicate the full appearance of the variant, which is so far largely uncommon, although it is much more virulent than the original strain of COVID-19.
CLICK HERE TO GET THE FOX NEWS APP
“Although the South African variant did break through the protection of the vaccine, it did not spread widely among the population,” Stern said.
Israel has conducted a number of important studies on the effectiveness of the vaccine, as the country approves the vaccination for more than 50% of the population. About a third of the population is under the age of 16, which means they are not eligible for the shot.